Alessandro Armuzzi

Humanitas University

Italy

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Immunology

40%

Internal Medicine

60%

Gastroenterology

100%

Inflammatory Bowel Disease

100%

Inflammatory Disease

100%

Inflammatory Biology

60%

Graft-versus-host Disease

40%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles30

The ‘totality of evidence’ and ‘extrapolation’ of SB17, a ustekinumab biosimilar

Article Link

Year:

2025

Efficacy and Safety of Infliximab and Vedolizumab Maintenance Therapy in Patients with Crohn’s Disease and Ulcerative Colitis: A Systematic Review and Meta-Analysis

Article Link

Year:

2025

Guidance for Fecal Microbiota Transplantation Trials in Ulcerative Colitis: The Second ROME Consensus Conference

Article Link

Year:

2025

What’s new in IBD research? Refining the agenda: Outcomes, patient-centered care, and technology

Article Link

Year:

2025

Author's reply: “Enhancing the validity of histologic assessments in UC-IPAA outcomes: A critique”

Article Link

Year:

2025

Therapeutic adherence in inflammatory bowel disease: User guide from a multidisciplinary modified Delphi consensus

Article Link

Year:

2025

Navigating Neoplasm Risk in Inflammatory Bowel Disease and Primary Sclerosing Cholangitis

Article Link

Year:

2025

Adaptation of the European Crohn's Colitis Organisation quality of care standards to Italy: The Italian Group for the study of inflammatory bowel disease consensus

Article Link

Year:

2025

Collecting and Analyzing IBD Clinical Data for Machine-Learning: Insights from an Italian Cohort

Article Link

Year:

2025

TL1A as a Target in Inflammatory Bowel Disease: Exploring Mechanisms and Therapeutic Potential

Article Link

Year:

2025

The learning curve for using intestinal ultrasonography

Article Link

Year:

2024

How comparative studies can inform treatment decisions for Crohn’s disease

Article Link

Year:

2024

Transperineal Ultrasonography in the Assessment of Rectal Inflammation: Beyond the Monitoring of Ulcerative Colitis

Article Link

Year:

2024

Hereditary Colorectal Cancer Syndromes and Inflammatory Bowel Diseases: Risk Management and Surveillance Strategies

Article Link

Year:

2024

Reporting of Magnetic Resonance Enterography in Inflammatory Bowel Disease: Results of an Italian Survey

Article Link

Year:

2024

Eosinophils, Eosinophilic Gastrointestinal Diseases, and Inflammatory Bowel Disease: A Critical Review

Article Link

Year:

2024

Residual Disease Burden Among European Patients With Inflammatory Bowel Disease: A Real-World Survey

Article Link

Year:

2024

Cardiovascular Safety of Ozanimod in Patients With Ulcerative Colitis: True North and Open-Label Extension Analyses

Article Link

Year:

2024

Histologic Disease Persists beyond Mucosal Healing and Could Predict Reactivation in Ulcerative Colitis

Article Link

Year:

2024

Management of Post-Operative Crohn’s Disease: Knowns and Unknowns

Article Link

Year:

2024

Fibro-Stenosing Crohn’s Disease: What Is New and What Is Next?

Article Link

Year:

2023

Pomegranate Extract Affects Gut Biofilm Forming Bacteria and Promotes Intestinal Mucosal Healing Regulating the Crosstalk between Epithelial Cells and Intestinal Fibroblasts

Article Link

Year:

2023

Checkpoint Inhibitor-Induced Colitis: From Pathogenesis to Management.

Article Link

Year:

2023

Comparison of Short- and Long-Term Effectiveness between Anti-TNF and Ustekinumab after Vedolizumab Failure as First-Line Therapy in Crohn’s Disease: A Multi-Center Retrospective Cohort Study

Article Link

Year:

2023

Sarcopenia: A new route on the map for risk stratification in inflammatory bowel disease

Article Link

Year:

2023

The gasdermin protein family: emerging roles in gastrointestinal health and disease

Article Link

Year:

2023

Mental Illnesses in Inflammatory Bowel Diseases: mens sana in corpore sano

Article Link

Year:

2023

Cytokines in Spondyloarthritis and Inflammatory Bowel Diseases: From Pathogenesis to Therapeutic Implications

Article Link

Year:

2023

The role of ustekinumab and vedolizumab in management of extra intestinal manifestations in inflammatory bowel disease

Article Link

Year:

2023

Characteristics, clinical outcomes and patient-reported outcomes of patients with ulcerative colitis receiving tofacitinib: a real-world survey in the United States and five European countries

Article Link

Year:

2023

Collaborators20

Henit Yanai

ISRAEL

Armando Santoro

Professore

Humanitas University

ITALY

David Drobne

SLOVENIA

Nicholas Kennedy

Honorary Clinical Senior Lecturer

University of Exeter

UNITED KINGDOM

Luis Puig

University of Barcelona

SPAIN

Stephen Hanauer

Professor of Medicine

Northwestern University

UNITED STATES

Flavio Caprioli

Associate professor

Università degli Studi di Torino

ITALY

Triana Lobaton Ortega

Ghent University Hospital

BELGIUM

Nick Powell

Reader in Gastroenterology

Imperial College London

UNITED KINGDOM

Byong Duk Ye

Professor

University of Ulsan College of Medicine

SOUTH KOREA

Ana LLEO

Professor of Internal Medicine

Humanitas University

ITALY

Roberto Rusconi

Humanitas University

ITALY

Valeria Cento

Associate Professor

Humanitas University

ITALY

Alessandro Repici

Humanitas University

ITALY

Alfredo PAPA

Professore Associato

Università Cattolica del Sacro Cuore

ITALY

Axel Dignass

Goethe University Frankfurt

GERMANY

Antonino Spinelli

Full Professor od Surgery

Humanitas University

ITALY

stefania vetrano

Assistant professor

Humanitas University

ITALY

Davide Giuseppe Ribaldone

Professore associato

ITALY

Edoardo Savarino

Associate Professor

University of Padua

ITALY

How do I reach out?

Meet Kite AI